Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.

Kauko O, O'Connor CM, Kulesskiy E, Sangodkar J, Aakula A, Izadmehr S, Yetukuri L, Yadav B, Padzik A, Laajala TD, Haapaniemi P, Momeny M, Varila T, Ohlmeyer M, Aittokallio T, Wennerberg K, Narla G, Westermarck J.

Sci Transl Med. 2018 Jul 18;10(450). pii: eaaq1093. doi: 10.1126/scitranslmed.aaq1093.

PMID:
30021885
2.

Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer.

Kauko O, Westermarck J.

Int J Biochem Cell Biol. 2018 Mar;96:157-164. doi: 10.1016/j.biocel.2018.01.005. Epub 2018 Jan 31. Review.

PMID:
29355757
3.

PWP1 Mediates Nutrient-Dependent Growth Control through Nucleolar Regulation of Ribosomal Gene Expression.

Liu Y, Mattila J, Ventelä S, Yadav L, Zhang W, Lamichane N, Sundström J, Kauko O, Grénman R, Varjosalo M, Westermarck J, Hietakangas V.

Dev Cell. 2017 Oct 23;43(2):240-252.e5. doi: 10.1016/j.devcel.2017.09.022.

4.

Phosphonormalizer: an R package for normalization of MS-based label-free phosphoproteomics.

Saraei S, Suomi T, Kauko O, Elo LL, Stegle O.

Bioinformatics. 2018 Feb 15;34(4):693-694. doi: 10.1093/bioinformatics/btx573.

PMID:
28968644
5.

Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56.

Wang J, Okkeri J, Pavic K, Wang Z, Kauko O, Halonen T, Sarek G, Ojala PM, Rao Z, Xu W, Westermarck J.

EMBO Rep. 2017 Mar;18(3):437-450. doi: 10.15252/embr.201642788. Epub 2017 Feb 7.

6.

Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling.

Kauko O, Laajala TD, Jumppanen M, Hintsanen P, Suni V, Haapaniemi P, Corthals G, Aittokallio T, Westermarck J, Imanishi SY.

Sci Rep. 2015 Aug 17;5:13099. doi: 10.1038/srep13099.

7.

Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.

Khanna A, Kauko O, Böckelman C, Laine A, Schreck I, Partanen JI, Szwajda A, Bormann S, Bilgen T, Helenius M, Pokharel YR, Pimanda J, Russel MR, Haglund C, Cole KA, Klefström J, Aittokallio T, Weiss C, Ristimäki A, Visakorpi T, Westermarck J.

Cancer Res. 2013 Nov 15;73(22):6757-69. doi: 10.1158/0008-5472.CAN-13-1002. Epub 2013 Sep 26.

8.

Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens.

Väänänen RM, Lilja H, Cronin A, Kauko L, Rissanen M, Kauko O, Kekki H, Vidbäck S, Nurmi M, Alanen K, Pettersson K.

Clin Biochem. 2013 May;46(7-8):670-4. doi: 10.1016/j.clinbiochem.2013.01.019. Epub 2013 Feb 4.

9.

CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.

Niemelä M, Kauko O, Sihto H, Mpindi JP, Nicorici D, Pernilä P, Kallioniemi OP, Joensuu H, Hautaniemi S, Westermarck J.

Oncogene. 2012 Sep 27;31(39):4266-78. doi: 10.1038/onc.2011.599. Epub 2012 Jan 16.

PMID:
22249265
10.

An 8-hour system for Salmonella detection with immunomagnetic separation and homogeneous time-resolved fluorescence PCR.

Hagren V, von Lode P, Syrjälä A, Korpimäki T, Tuomola M, Kauko O, Nurmi J.

Int J Food Microbiol. 2008 Jul 15;125(2):158-61. doi: 10.1016/j.ijfoodmicro.2008.03.037. Epub 2008 Apr 4.

PMID:
18501459
11.

Quantitative real-time RT-PCR assay for PCA3.

Väänänen RM, Rissanen M, Kauko O, Junnila S, Väisänen V, Nurmi J, Alanen K, Nurmi M, Pettersson K.

Clin Biochem. 2008 Jan;41(1-2):103-8. Epub 2007 Oct 26.

PMID:
17996198
12.

The effects of alcohol on the perception of musical stimuli. An orientative experimental study.

PIHKANEN T, KAUKO O.

Ann Med Exp Biol Fenn. 1962;40:275-82. No abstract available.

PMID:
13943532

Supplemental Content

Support Center